Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 328152, 10 pages
http://dx.doi.org/10.1155/2014/328152
Review Article

Large Dosage of Chishao in Formulae for Cholestatic Hepatitis: A Systematic Review and Meta-Analysis

1Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China
2China Military Institute of Chinese Medicine, 302 Hospital of People's Liberation Army, Beijing 100039, China
3Department of Evidence-Based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University, Chengdu 610041, China
4State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China
5Department of Integrative Medical Center, 302 Hospital of People's Liberation Army, Beijing 100039, China

Received 3 April 2014; Accepted 15 May 2014; Published 2 June 2014

Academic Editor: Zunjian Zhang

Copyright © 2014 Xiao Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Jin, D. Cheng, J. Y. Tao et al., “Anti-inflammatory and anti-oxidative effects of corilagin in a rat model of acute cholestasis,” BMC Gastroenterology, vol. 13, no. 1, article 79, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Zhao, G. Zhou, J. Wang et al., “Paeoniflorin protects against ANIT-induced cholestasis by ameliorating oxidative stress in rats,” Food and Chemical Toxicology, vol. 58, pp. 242–248, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Zhu, H. Cao, X. Zhou et al., “Meta-analysis of the clinical value of danshen injection and huangqi injection in liver cirrhosis,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 842824, 8 pages, 2013. View at Publisher · View at Google Scholar
  4. D. Yang, G. J. Gao, K. Wei, X. J. Wang, and F. X. Sun, “Clinical analysis of cholestatic hepatitis characteristic,” Chinese Journal of Clinicians, vol. 5, no. 24, pp. 7423–7424, 2011. View at Google Scholar
  5. D. Yang, F. X. Sun, G. J. Gao, K. Wei, and X. J. Wang, “Evaluation on herbal Yudan decoction on treatment of acute cholestatic hepatitis,” Chinese Journal of Liver Diseases, vol. 5, no. 3, pp. 9–11, 2013. View at Google Scholar
  6. L. Zhang, G. Wang, W. Hou, P. Li, A. Dulin, and H. L. Bonkovsky, “Contemporary clinical research of traditional chinese medicines for chronic hepatitis B in china: an analytical review,” Hepatology, vol. 51, no. 2, pp. 690–698, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Xia, H. Luo, J. P. Liu, and C. Gluud, “Phyllanthus species for chronic hepatitis B virus infection,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD008960, 2011. View at Google Scholar · View at Scopus
  8. H. M. Liu, X. B. Wang, Y. J. Chang, and L. L. Gu, “Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis,” Journal of Chinese Integrative Medicine, vol. 10, no. 11, pp. 1211–1228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Li and B. Zhang, “Traditional Chinese medicine network pharmacology: theory, methodology and application,” Chinese Journal of Natural Medicines, vol. 11, no. 2, pp. 110–120, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Li, Z. Q. Zhang, L. J. Wu, X. G. Zhang, Y. D. Li, and Y. Y. Wang, “Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network,” IET Systems Biology, vol. 1, no. 1, pp. 51–60, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. C. B. Wang, J. P. He, Z. Y. Lei, and J. M. Chen, “Treating cholestatic hepatitis with large dosage of Chishao for cooling blood and promoting blood flow—13 cases report,” Journal of Traditional Chinese Medicine, no. 6, pp. 30–32, 1983. View at Google Scholar
  12. J. P. He and C. B. Wang, “Treatment of severe cholestatic hepatitis by integrative medicines,” Chinese Journal of Integrative Medicine, vol. 4, no. 1, pp. 18–21, 1998. View at Google Scholar
  13. S. S. Wei, Y. L. Zhao, F. J. Jiang et al., “Investigation of high dosage of Paeoniae Radix Rubra against ANIT-induced acute cholestasis hepatitis in rats,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 18, no. 12, pp. 151–155, 2012. View at Google Scholar
  14. X. Q. Tang, W. Q. Xu, and X. J. Cheng, “Yinchen Xiaodan method combined with western medicine in treatment of chronic hepatitis B with intrahepatic cholestasis randomized parallel controlled study,” Journal of Practical Traditional Chinese Internal Medicine, vol. 27, no. 3, pp. 79–80, 2013. View at Google Scholar
  15. Z. Q. Chen and Y. Y. Tu, “Clinical observation of 30 cases of cholestatic hepatitis treating with ancient Jiawei prescription,” Inner Mongol Journal of Traditional Chinese Medicine, vol. 12, pp. 18–19, 2013. View at Google Scholar
  16. Q. B. Wu, “control observation of Huoxue Qingdan decoction in treating chronic cholestatic hepatitis,” Journal of Practical Traditional Chinese Internal Medicine, vol. 26, no. 8, pp. 49–51, 2012. View at Google Scholar
  17. C. J. Xu, W. S. Guo, and Y. F. Xie, “Clinical observation of 30 cases of severe cholestatic hepatitis treating with combined tratitional Chinsese medicine and western medicine,” Modern Journal of Integrated Traditional Chinese and Western Medicine, vol. 20, no. 20, pp. 2531–2532, 2011. View at Google Scholar
  18. X. J. Zhu, “Clinical observation of cholestatic hepatitis treated with large dose Chishao,” Clinical Journal of Traditional Chinese Medicine, vol. 22, no. 2, pp. 144–145, 2010. View at Google Scholar
  19. S. M. He, B. Huang, and X. Deng, “32 Cases of severe cholestatic hepatitis treated with Chi Yin Tui Huang decoction combined with western medicine,” Shaanxi Journal of Traditional Chinese Medicine, vol. 29, no. 5, pp. 564–566, 2008. View at Google Scholar
  20. C. J. Xie, W. B. Ma, R. C. Li, and S. Y. Wang, “60 Cases of cholestatic hepatitis treated with Chishao Tuihuang decoction research,” Capital Medicine, vol. 6, p. 49, 2008. View at Google Scholar
  21. Z. E. Shu, Clinical Observation of Chronic Cholestatic Hepatitis Treated with Wen Li Huo Xue Decoction, Hubei University of Chinese Medicine, 2007.
  22. Y. F. Li, Clinical Observation of Chronic Viral Cholestatic Hepatitis After Treatment with Jian Pi Li Dan Decoction, Hubei University of Chinese Medicine, 2006.
  23. J. P. He, C. B. Wang, J. B. Ding et al., “Comparison of Chidan Tuihuang granule and Galle-Donau in the treatment of acute and chronic viral cholestatic hepatitis,” Chinese Journal of New Drugs, vol. 12, no. 3, pp. 209–212, 2003. View at Google Scholar
  24. J. P. He, C. B. Wang, J. B. Ding et al., “Open comparative study of Chidan Tuihuang granule in treating acute and chronic viral cholestatie hepatitis,” Chinese Journal of Integrated Traditional and Wetern Medicine, vol. 23, no. 7, pp. 498–500, 2003. View at Google Scholar
  25. Chinese Medical Association, “Viral hepatitis prevention and treatment programs,” Infectious Disease Information, vol. 13, no. 4, pp. 141–150, 2000. View at Google Scholar
  26. X. Y. Zheng, Guidance for Clinical Research on New Drugs of TCM, China Medical Science Press, 2002.
  27. R. Poupon, O. Chazouilleres, and R. E. Poupon, “Chronic cholestatic diseases,” Journal of Hepatology, vol. 32, no. 1, supplement, pp. 129–140, 2000. View at Google Scholar · View at Scopus
  28. S. Kakizaki, D. Takizawa, H. Tojima, N. Horiguchi, Y. Yamazaki, and M. Mori, “Nuclear receptors CAR and PXR; therapeutic targets for cholestatic liver disease,” Frontiers in Bioscience, vol. 16, no. 7, pp. 2988–3003, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Anthérieu, P. B. Azzi, J. Dumont et al., “Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells,” Hepatology, vol. 57, no. 4, pp. 1518–1529, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Allen, H. Jaeschke, and B. L. Copple, “Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis,” The American Journal of Pathology, vol. 178, no. 1, pp. 175–186, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Geier, M. Wagner, C. G. Dietrich, and M. Trauner, “Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1773, no. 3, pp. 283–308, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Keppler, “Cholestasis and the role of basolateral efflux pumps,” Zeitschrift für Gastroenterologie, vol. 49, no. 12, pp. 1553–1557, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Buryova, K. Chalupsky, O. Zbodakova et al., “Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity,” BMC Gastroenterology, vol. 13, no. 1, article 155, 2013. View at Publisher · View at Google Scholar
  34. F. Arenas, I. Hervias, M. Úriz, R. Joplin, J. Prieto, and J. F. Medina, “Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells,” Journal of Clinical Investigation, vol. 118, no. 2, pp. 695–709, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. Z. Fang, B. Lu, M. Liu et al., “Evaluating the pharmacological mechanism of Chinese medicine Si-Wu-Tang through multi-level data integration,” PLoS ONE, vol. 8, no. 11, Article ID e72334, 2013. View at Publisher · View at Google Scholar
  36. J. Liu, M. Pei, C. Zheng et al., “A systems-pharmacology analysis of herbal medicines used in health improvement treatment: predicting potential new drugs and targets,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 938764, 17 pages, 2013. View at Publisher · View at Google Scholar
  37. A. Zhang, H. Sun, S. Qiu, and X. Wang, “Advancing drug discovery and development from active constituents of Yinchenhao Tang, a famous traditional Chinese medicine formula,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 257909, 6 pages, 2013. View at Publisher · View at Google Scholar
  38. Y. Z. Wang, W. S. Feng, R. B. Shi, B. Liu, and Y. Y. Jiang, “Monoterpenes of Paeonia lactiflora Pall,” Chinese Pharmaceutical Journal, vol. 43, no. 9, pp. 669–671, 2008. View at Google Scholar · View at Scopus
  39. Y. Y. Yang, G. Zhou, X. K. Ma et al., “Research progress of Paeonia lactiflora Pall,” Herald of Medicine, vol. 27, no. 1, pp. 67–69, 2008. View at Google Scholar
  40. S. N. Jin, J. F. Wen, T. T. Wang, D. G. Kang, H. S. Lee, and K. W. Cho, “Vasodilatory effects of ethanol extract of Radix Paeoniae Rubra and its mechanism of action in the rat aorta,” Journal of Ethnopharmacology, vol. 142, no. 1, pp. 188–193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. B. Lee, Y. W. Shin, E. A. Bae et al., “Antiallergic effect of the root of Paeonia lactiflora and its constituents paeoniflorin and paeonol,” Archives of Pharmacal Research, vol. 31, no. 4, pp. 445–450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Y. He and S. M. Dai, “Anti-inflammatory and immunomodulatory effects of Paeonia lactiflora Pall., a traditional Chinese herbal medicine,” Frontiers in Pharmacology, vol. 2, article 10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. É. Bourbonnais, V. Raymond, C. Éthier et al., “Liver fibrosis protects mice from acute hepatocellular injury,” Gastroenterology, vol. 142, no. 1, pp. 130.e4–139.e4, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. J. B. Wang, H. P. Zhao, Y. L. Zhao et al., “Hepatotoxicity or hepatoprotection? pattern recognition for the paradoxical effect of the chinese herb Rheum palmatum L. in treating rat liver injury,” PLoS ONE, vol. 6, no. 9, Article ID e24498, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Jiang, Y. Zhao, J. Wang et al., “Comparative pharmacokinetic study of paeoniflorin and albiflorin after oral administration of Radix Paeoniae Rubra in normal rats and the acute cholestasis hepatitis rats,” Fitoterapia, vol. 83, no. 2, pp. 415–421, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. F. Liaw, “Impact of therapy on the outcome of chronic hepatitis B,” Liver International, vol. 33, supplement 1, pp. 111–115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. F. M. Marincola, “Translational medicine: a two-way road,” Journal of Translational Medicine, vol. 1, no. 1, article 1, 2003. View at Publisher · View at Google Scholar · View at Scopus